Uncovering how the body ages is leading to drugs to reverse it
Young blood not required
IN 2016 A startup in California called Ambrosia began offering its customers transfusions of blood from the young. At $8,000 per litre, it was a service for the wealthy who believed that young blood could slow down or reverse the ageing process, thereby reducing their chances of developing cancers, Alzheimer’s disease and heart disease.
This article appeared in the Science & technology section of the print edition under the headline “Rejuvenation juice”
Science & technology September 14th 2019
From the September 14th 2019 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Can you breathe stress away?
Scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship
A better understanding of Huntington’s disease brings hope
Previous research seems to have misinterpreted what is going on
Is obesity a disease?
It wasn’t. But it is now
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
Those with the syndrome have more of a protein implicated in dementia
Should you start lifting weights?
You’ll stay healthier for longer if you’re strong